MMedication Read More SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous UrticariaNovember 26, 2025 Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…